Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis - results from multicenter observational cohort.
Anita BálintMariann RutkaMartin KolarDana DuricovaVeronika HrubaKatarina MitrovaKarin MalickovaMilan LukasZoltán SzepesFerenc NagyKároly PalatkaSzilvia LovasZsuzsanna VéghZsuzsanna KürtiÁgnes CsontosPál MihellerTibor NyáriRenáta BorAnna FábiánKata Judit SzántóPéter L LakatosTamás MolnárKlaudia FarkasPublished in: Expert opinion on biological therapy (2018)
Our study confirmed the long-term efficacy of CT-P13 therapy on mucosal healing in UC.